NEWS
AmCham News tags
- Accounting / Financial
- AmCham Norway
- Company Profiles
- Education / Research
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Hotel/ Restaurants/ Conferences
- Insurance
- International Leadership Interview Series
- Membership Guide
- Publications
- Rising Leaders
- Technology
- Trade
- Travel
Archive tags
Business News tags
- Accounting / Financial
- Airline / Travel
- Automobile / Transport
- Chemicals / Metals
- Communications/PR/Media
- Culture / Lifestyle
- Defense / Security
- Education / Research
- Energy
- Entertainment & Lifestyle
- Financial / Investment
- Food & Beverage
- Government
- Health
- Human Resources
- Insurance
- IP & Innovation
- Legal
- Management Consulting
- Manufacturing
- Pharmaceutical
- Politics
- Property / Real Estate
- Seafood
- Shipping & Offshore
- Statistics
- Tax
- Technology
- Trade
Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics
Category: Business News
Oslo, Norway – June 4, 2026 – Photocure ASA (OSE: PHO), a leader in bladder cancer diagnostics, today announced the signing and successful completion of its acquisition of Vesica Health, a U.S. established precision diagnostics company advancing AssureMDx, a urine-based molecular test for the early detection of bladder cancer, in a transaction designed to expand […]
Source: Photocure
More
US Chamber: US Medical Innovation has Delivered $167.5T in Societal Value”
Category: Business News
Groundbreaking Study Reveals $167 Trillion in Societal Value Generated by American Medical Innovation. New analysis highlights the human and economic impact of medical breakthroughs as policymakers consider harmful MFN‑style pricing controls WASHINGTON, D.C. – A pioneering new study by University of Chicago economist Dr. Tomas Philipson, commissioned by the U.S. Chamber of Commerce, finds that […]
Source: U.S. Chamber of Commerce
More
Trump’s MFN drug pricing impact still unclear in Denmark and Sweden
Category: Business News
With the US administration’s Most Favoured Nation (MFN) drug pricing policy still hanging over Europe, Denmark and Sweden, two of the affected countries, are investigating its potential impact. The MFN policy, set out in an executive order by US President Donald Trump in May 2025, aims to force global drug manufacturers to reduce the price […]
Source: Euractiv
More
Farmatopper, beslutningstakere og politikere møttes for å diskutere “Most Favored Nation”
Category: Business News
Source: HealthTalk
More
Kronikk: USA har rett om legemiddelpriser
Category: Business News
Kronikken er skrevet av Ketil Widerberg, daglig leder i Oslo Cancer Cluster. USAs såkalte Most Favoured Nation-strategi for legemiddelpriser har blitt møtt med kraftig kritikk. Den fremstilles som usosial, proteksjonistisk og farlig for pasienter. Prising og refusjon behandles som rene nasjonale spørsmål Men bak den harde retorikken ligger et poeng vi i Europa – og […]
Source: MedWatch
More